Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease

Amyloid-β (Aβ) accumulation and tauopathy are considered the pathological hallmarks of Alzheimer’s disease (AD), but attenuation in choline signaling, including decreased nicotinic acetylcholine receptors (nAChRs), is evident in the early phase of AD. Currently, there are no drugs that can suppress...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kazuyuki Takata, Hiroyuki Kimura, Daijiro Yanagisawa, Koki Harada, Kaneyasu Nishimura, Yoshihisa Kitamura, Shun Shimohama, Ikuo Tooyama
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2022-04-01
Serie:Molecules
Ämnen:
neurodegenerative disease
nicotinic acetylcholine receptors
glial cells
neuroprotection
neuroinflammation
subtype
Länkar:https://www.mdpi.com/1420-3049/27/9/2780
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk